Hospital
Citizens Medical Center County of Victoria
Citizens Medical Center County of Victoria was paid $1.70M by Medicaid between Sep 2020 and Dec 2024, across 59 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoCITIZENS MEDICAL CENTER COUNTY OF VICTORIA
VICTORIA, TX 77901
VICTORIA, TX 77901
33aNPI1124052162assigned 07/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.70M
24GClaims60,602
24DCodes billed59
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#53 of 109
Median peer was paid$1.15M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BROWN, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 352 | $15K | |
| 2021 | 14,677 | $311K | |
| 2022 | 19,685 | $520K | |
| 2023 | 16,163 | $654K | |
| 2024incomplete | 9,725 | $201K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 4,211 | 3,976 | $521K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 9,176 | 8,862 | $397K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 2,229 | 2,099 | $199K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.6% | 1,292 | 1,247 | $163K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 6.0% | 177 | 171 | $102K |
| 80053 | Comprehensive metabolic panel | 4.3% | 7,988 | 7,075 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 7,023 | 6,300 | $44K |
| 86328 | 2.5% | 1,185 | 1,156 | $43K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 883 | 841 | $39K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 336 | 321 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,225 | 1,129 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,236 | 1,157 | $10K |
47 more codes
| 87581 | <1% | 177 | $9K | |
| 87486 | <1% | 177 | $9K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 103 | $6K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 177 | $6K |
| 59025 | Fetal non-stress test | <1% | 67 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 78 | $4K |
| 81001 | <1% | 2,217 | $4K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 81 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 770 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 613 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,035 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 163 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 361 | $3K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 33 | $2K |
| 84703 | <1% | 586 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 174 | $2K |
| 83735 | <1% | 809 | $2K | |
| 83690 | <1% | 902 | $2K | |
| 85027 | <1% | 912 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 429 | $2K |
| 83880 | <1% | 452 | $2K | |
| 84484 | <1% | 943 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 51 | $939.60 |
| 81025 | <1% | 86 | $527.79 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 292 | $479.74 |
| 85610 | <1% | 499 | $367.09 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,954 | $366.86 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $287.50 |
| 85730 | <1% | 270 | $267.65 | |
| 81003 | <1% | 353 | $192.40 | |
| 87088 | <1% | 69 | $129.20 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 122 | $121.29 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 120 | $81.43 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 643 | $69.37 |
| 84702 | <1% | 53 | $63.20 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 40 | $57.12 |
| 86885 | <1% | 26 | $52.80 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 45 | $29.34 |
| 86901 | <1% | 55 | $27.61 | |
| 86900 | <1% | 56 | $27.61 | |
| 87077 | <1% | 13 | $27.16 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | $16.83 |
| 82728 | <1% | 18 | $11.45 | |
| 80061 | Lipid panel | <1% | 12 | $6.89 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 26 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 30 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 525 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWN, DAVID (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Childrens Dentistry of Wichita | Wichita, KS | $32.73M |
| Family Care Partners of Northeast Florida LLC | Jacksonville, FL | $8.27M |
| Allergy Partners, PLLC | Winston Salem, NC | $6.58M |
| Allergy Partners, PLLC | Asheville, NC | $5.49M |
| Orlando Family Physicians, LLC | Orlando, FL | $5.48M |
| Allergy Partners, PLLC | Albuquerque, NM | $5.00M |
| Allergy Partners, PLLC | Fayetteville, NC | $3.24M |
| Allergy Partners, PLLC | Indianapolis, IN | $3.16M |
| Allergy Partners, PLLC | Greenville, SC | $2.95M |
| Allergy Partners of NJ, PC | Teaneck, NJ | $2.41M |
| Allergy Partners, PLLC | Spartanburg, SC | $2.24M |
| Allergy Partners, PLLC | Williamsburg, VA | $2.03M |
| Allergy Partners, PLLC | Cynthiana, KY | $1.79M |
| Allergy Partners, PLLC | Richmond, VA | $1.75M |
| Allergy Partners, PLLC | Wilmington, NC | $1.71M |
| Allergy Partners, PLLC | West Columbia, SC | $1.61M |
| Allergy Partners, PLLC | Pinehurst, NC | $1.56M |
| Allergy Partners, PLLC | Greenville, NC | $1.42M |
| Allergy Partners of California, INC. | San Luis Obispo, CA | $1.39M |
| Allergy Partners, PLLC | Santa Fe, NM | $1.37M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.